Sports
Half Year Median Technologies Liquidity Contract Statement
SOPHIA ANTIPOLIS, France, January 07, 2026--Regulatory News: Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were listed in the liquidity account as of December 31, 2025:
About this update from Median Technologies
SOPHIA ANTIPOLIS, France, January 07, 2026 --( BUSINESS WIRE )--Regulatory News: Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were listed in the liquidity account as of December 31, 2025: Transactions during the second half of 2025: For information, as of June 30, 2025, the following resources were listed in the liquidity contract: For information, as of May 4th, 2020, when the new liquidity contract was set up, the following resources were listed in the liquidity account: The daily transaction table is provided in the appendix to this press release. TP ICAP (Europe) is authorized and regulated by the Autorité de Contrôle Prudentiel (ACPR) and the Autorité des Marchés Financiers (AMF). About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis®, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com . APPENDIX: DAILY TRANSACTIONS View source version on businesswire.com: https://www.businesswire.com/news/home/20260107104217/en/ Contacts MEDIAN TECHNOLOGIES Emmanuelle Leygues VP, Corporate Marketing & Financial Communications +33 6 10 93 58 88 [email protected] Investors - SEITOSEI ACTIFIN Ghislaine Gasparetto +33 6 85 36 76 81 [email protected] Press – ULYSSE COMMUNICATION Bruno Arabian +33 6 87 88 47 26 [email protected] Nicolas Entz +33 6 33 67 31 54 [email protected]
View stock analysis, news, and events for Median Technologies